)
Company Research29 Mar 2024
Companies That Had Their IPO in 1992: A Cautiously Optimistic Market
1992 marked a relatively cool IPO landscape and stock market sentiment, in the wake of the early 90s recession.
Boston Scientific (BSX) investor relations material
Boston Scientific Wolfe Research Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Wolfe Research Healthcare Conference 2025 summary18 Nov, 2025
Key growth drivers and clinical trial insights
Watchman and ablation portfolio are central to growth, with double-digit growth expected for Watchman, supported by recent clinical data and expanded indications.
Closure trial failed non-inferiority due to high procedural complications and use of older devices, not due to device efficacy in stroke prevention.
Real-world data and newer devices like Watchman Flex show improved outcomes, suggesting trial results may not reflect current practice.
Low-risk patient trials (OSHN, Alone) support ablation without long-term anticoagulation, but do not impact Watchman’s target population or growth.
Concomitant procedures and improved CMS coverage are driving increased Watchman adoption, with 25% of implants expected to be concomitant by end of 2025.
Market expansion, reimbursement, and regulatory outlook
Champion trial results expected in the first half of 2026, with potential to reinforce confidence and expand indications for Watchman.
Positive Champion results could accelerate market growth, especially internationally, and may prompt label and reimbursement changes in the U.S.
Label update and CMS NCD revision could take up to 19 months post-trial, based on prior experience.
Option trial and expanded indications have added 1–2 million more eligible patients globally, with about half in the U.S.
Ablation technology and competitive landscape
FARAPulse PFA is seeing high adoption, with U.S. penetration expected to exceed 50% in 2025, focused on de novo ablations.
FARAPulse and Watchman growth are mutually reinforcing, with new procedures (FARAWatch) enabled by improved safety and predictability.
Single-digit redo rates at one year for de novo ablations with FARAPulse, shifting the market away from high redo rates.
Opal mapping system offers unique advantages for PFA, including better visualization and economic benefits in ambulatory settings.
Competition in PFA is seen as expanding the market, with FARAPulse focused on the larger de novo segment.
How does BSC counter Closure trial's negative impact?
How do FARAPULSE redo rates impact market?
How is TIVUS RDN safety ensured without cooling?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Boston Scientific earnings date
Citi Annual Global Healthcare Conference 20252 Dec, 2025
Next Boston Scientific earnings date
Citi Annual Global Healthcare Conference 20252 Dec, 2025
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Boston Scientific Corporation designs, develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company's products include heart valves, falls prevention and mobility solutions, peripheral intervention devices, endovascular systems and services, and electrophysiology products. The company also provides a range of minimally invasive surgical procedures based on its innovative tissue acquisition technologies to expand the therapeutic applications for new drug therapies for gastrointestinal tract disorders. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage